Alaska's Prescription Drug Monitoring Program

FAQ: Pharmacist Responsibilities and the PDMP

Starting July 17, 2017:

• Mandatory registration by all pharmacists who dispense a federally controlled substances II, III and IV and DEA registered prescribers licensed in the State of Alaska.
• Practitioner must review PDMP information before dispensing, prescribing, or administering a federal schedule II or III controlled substance. The exception(s) are:
  
  • receiving treatment in an inpatient setting;
  • at the scene of an emergency or in an ambulance;
  • in an emergency room;
  • immediately before, during, or within the first 48 hours after surgery or a medical procedure;
  • in a hospice or nursing home that has an in house pharmacy;
  • a nonrefillable prescription of a controlled substance in a quantity intended to last for not more than three days.
• Collection of all schedule II, III, or IV controlled substances dispensed in the state; schedule V controlled substances are no longer collected.
• Delegate access is now allowed, but with limitations; a registered pharmacist or prescriber may allow access to the PDMP by an agent or employee, who is licensed or registered under AS 08, by creating a sub-account within the PDMP under their corresponding prescriber or pharmacist account. Sign up instructions for delegates are coming soon.
• Unsolicited reports may be provided to both prescribers and pharmacists when a patient appears to be receiving multiple Schedule II-IV prescriptions from multiple pharmacies and multiple prescribers; the current threshold is set at 5 prescribers / 5 dispensers in a 3-month period.
• Reporting frequency of controlled substances dispensed will change to weekly.

PDMP Web Page:     Register   |   Sign In   |   Submit Data   |   Find Information

Joint Committee on Prescriptive Guidelines Report to Alaska State Legislature

Learn more about reducing addiction at:  Opioids.Alaska.Gov